StonvexLoading…
StonvexStonvexStonvexCore line items from UDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.53M | $11.36M | $7.08M | $4.51M |
Operating Income | $229.81M | $553.61M | $275.94M | $199.58M |
Net Income | $189.83M | $377.70M | $154.80M | $114.39M |
EPS (Diluted) | $0.57 | $1.13 | $0.46 | $0.34 |
Total Assets | $10.33B | $10.61B | $10.60B | $10.65B |
Total Liabilities | $6.23B | $6.46B | $6.45B | $6.36B |
Cash & Equivalents | $1.30M | $1.22M | $1.19M | $1.53M |
Free Cash Flow OCF − CapEx | $85.28M | $650.03M | $457.91M | $293.30M |
Shares Outstanding | 325.89M | 328.27M | 330.77M | 331.29M |